Study ID: TVP - 1012/135 Double Blind
Study Title
- Rasagiline in Advanced Parkinson's Disease Patients With Motor Fluctuations Treated With Levodopa/Carbidopa Therapy.
Teva Identifier
- TVP - 1012/135 Double Blind
ClinicalTrials.gov Identifier
- NCT00203177
Study Status
- Completed
Trial Condition(s)
- Parkinson's Disease
Interventions
- Drug: rasagiline mesylate | Drug: rasagiline mesylate 1.0 mg
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
Gender
- Female, Male
Age Range
- 30 Years and older
Trial Duration
- 10/01/2001 - 01/00/1900
Phase
- Phase 3
Study Type
Interventional
